GAD1 and temporal lobe epilepsy: GAD antibodies are the most frequent antibody in SPSD and cerebellar ataxia, but they also associate with temporal lobe epilepsy, limbic encephalitis, and type 1 diabetes (Gresa-Arribas et al., 2015).